Immutep Corp - IMMP Net Assets per Single Share

Public company logo of Immutep Ltd (IMMP)

Immutep Limited (IMMP) maintains a narrow profile, focusing on the development of LAG-3 therapies, which makes its resilience dependent on global alliances. Meanwhile, the brand is highly valued by physicians for its success in combating breast tumors. This chart on GURU.Markets currently shows the price at 5.84. In the future, the business will generate revenue through the commercialization of immune-stimulating agents designed to destroy malignant cells.

Immutep Ltd (IMMP) - Accounting Value per Share from 07/04/2022 to 10/27/2026

Summary analytical data breakdowns for immutep.com (IMMP)

- price and consensus price forecast:
Price Chart Immutep Limited ADR|IMMP - Consensus Target
- market capitalization data:
Market Value Immutep Limited|IMMP - Full Business Value
- book capitalization data:
Book Value per Share Immutep|IMMP - Company Net Assets|Market Capitalization to Book Value Ratio immutep.com|IMMP - Company Total Assets
- debt and liquidity data:
Debt to Equity Immutep Limited|IMMP - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Immutep|IMMP - Company Total Debt|Debts to Book Capitalization Immutep Limited
Analysis of all company metrics:Immutep Limited ADR, IMMP
Manufactured product of immutep.com

Immutep Limited (IMMP) developments in targeted cancer immunotherapy based on the LAG-3 protein establish a valuable patent perimeter, capitalizing on the company's technological advantages. The current book value per share stands at 5.84, reflecting the share of net assets per unit of capital; growth in this indicator confirms strengthening financial stability, although investors should compare this figure with revenue dynamics to rule out stagnation.

Competitor analysis for Immutep Limited

MRUS: Net Assets per Single Share|ANIX: Accounting Value per Share|Net Assets per Single Share Atossa Therapeutics (ATOS)|Context Therapeutics Inc. (CNTX) - Share Book Value|Book Value per Share MRSN|Accounting Value per Share BriaCell Therapeutics Corp.|Book Value per Share EPIX|Book Value per Share QTI (QT Imaging, Inc.)